Showing results (41-50 of 63) with videos related to
Sort By:
Pageof 7
The Lancet. Oncology|July 24, 2020
Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling studyAmit Sud, Bethany Torr, Michael E Jones, et al.Scientific Reports|January 24, 2019
Mendelian randomization provides support for obesity as a risk factor for meningiomaHannah Takahashi, Alex J Cornish, Amit Sud, et al.Cell Reports|September 14, 2017
Genetic Predisposition to Multiple Myeloma at 5q15 Is Mediated by an ELL2 Enhancer PolymorphismNi Li, David C Johnson, Niels Weinhold, et al.Neuro-Oncology|May 19, 2019
A genome-wide association study identifies susceptibility loci for primary central nervous system lymphoma at 6p25.3 and 3p22.1: a LOC Network studyKarim Labreche, Mailys Daniau, Amit Sud, et al.Human Genomics|August 21, 2019
Transcriptome-wide association study of multiple myeloma identifies candidate susceptibility genesMolly Went, Ben Kinnersley, Amit Sud, et al.Blood|September 9, 2018
Genome-wide association study implicates immune dysfunction in the development of Hodgkin lymphomaAmit Sud, Hauke Thomsen, Giulia Orlando, et al.Scientific Reports|February 7, 2018
Mendelian randomisation study of the relationship between vitamin D and risk of gliomaHannah Takahashi, Alex J Cornish, Amit Sud, et al.Scientific Reports|May 24, 2019
Publisher Correction: Mendelian randomisation study of the relationship between vitamin D and risk of gliomaHannah Takahashi, Alex J Cornish, Amit Sud, et al.Nature Communications|December 3, 2017
Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibilityAmit Sud, Hauke Thomsen, Philip J Law, et al.Nature Communications|January 10, 2019
Author Correction: Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibilityAmit Sud, Hauke Thomsen, Philip J Law, et al.Pageof 7